Radiotherapy : ongoing Clinical Trials in Early-Stage Breast Cancer
Sithembile NGIDI
What are the opportunities brought by the BCU and what are the contributions of genetics to the management of breast cancer?
Pascal PUJOL
Chairman of the Genetic department, University Hospital, Montpellier, France
HER2-Targeted Therapies: Beyond Trastuzumab
Hassan GHAZAL
Biological and anatomo-pathological characteristics. How to improve financial items.
Frédérique PENAULT-LLORCA
Pathologist, Clermont Ferrand, France
Radiotherapy options.
Yazid BELKACEMI
Radiotherapist, Créteil, France